SYN - Agree totally. You also deserve just as much thanks! It's going to be a pretty cool ride over the next few months. Best thing though is that we now know this drug is out there and it WILL save people's lives!
"Shame the Dr said we have seen trials like this fail and June as an end date is quite a long way away"
Pathetic. Such poor journalism. Some of the most experienced respiratory disease professors in the world working on a drug to treat respiratory viral infections for 15 years and you go out and get a local GP, call them an expert and get them to speculate about the future trial success.
RE: Explanation for the newbies...12 Jan 2021 18:33
"bought back in again when it dropped then you seriously need some education on the way AIM works buddy"
Axe, I think that is a little unfair mate. There are many ways to play this game. I too have bought at 30p and also at 230p and many places in between. I have built a significant position and still have an average below £1. There was a lot going on in August/Sept/Oct and if EUA did come and you had sold at the top having had an average in the 40's you would have kicked yourself forever. I certainly wasn't going to be out with the hope it would drop back.
It was not until 9th November when **** hit the fan and for those who had researched and had belief it was just another great buying opportunity.
Agree@ notready. Yesterday's rns derisks the product. I think we all know here the real risk with this share is the jurisdiction they operate in. Hopefully the company can make that work. At least the noise coming out of government is positive with regard to international investment.
"Two of the study’s co-authors, Donna Davies, Ph.D., and Ratko Djukanovic, M.D., are co-founders and shareholders of Synairgen, which was spun out of the university."